| NDC Code | 45963-419-06 |
|---|
| Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (45963-419-06) |
|---|
| Product NDC | 45963-419 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ranolazine |
|---|
| Non-Proprietary Name | Ranolazine |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190528 |
|---|
| End Marketing Date | 20260531 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA208862 |
|---|
| Manufacturer | Actavis Pharma, Inc. |
|---|
| Substance Name | RANOLAZINE |
|---|
| Strength | 1000 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|